ABVC Forex News

ABVC BioPharma Gets Taiwanese Patent For Use Of Polygala Extract For Depressive Disorder

Biopharmaceutical company ABVC BioPharma, Inc. (ABVC) announced Monday that it received a Taiwanese patent, Application No. 109130285, for the use of PDC-1421, a Radix Polygala (Polygala tenuifolia Willd) extract, which is used in the Company's asset ABV-1504 for the treatment of Major Depressive Disorder (MDD).

RTTNews | 636 days ago

Terms | Privacy | Site Map | Site Map Calendar

HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment. Do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.

EURUSD	1.17797	GBPUSD	1.36503	AUDUSD	0.65512
USDJPY	144.407	USDCAD	1.3597	USDCHF	0.79348

Advertisement

ABVC Forex News

ABVC BioPharma Gets Taiwanese Patent For Use Of Polygala Extract For Depressive Disorder